west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "药物" 951 results
  • 暴露于新型抗癫痫发作药物后儿童神经发育结果的系统综述

    由于孕期暴露于某些传统的抗癫痫发作药物(Anti-seizure medications,ASMs)与儿童较差的神经发育有关,因此在整个妊娠期间使用新型ASMs的情况有所增加。本研究旨在阐明子宫内暴露于这些新型ASMs对儿童神经发育的影响。对MEDLINE、Embase、Web of Science、Cumulative Index to Nursing and Allied Health Literature Plus和PsycINFO进行了系统检索,结果仅限于2000年后发表的英文文章。调查宫内暴露于新型ASMs后神经发育结果的研究,纳入评价的药物包括:艾司利卡西平、加巴喷丁、拉考沙胺、拉莫三嗪、左乙拉西坦、奥卡西平、吡仑帕奈、托吡酯和唑尼沙胺,最终确定了35份发表的相关研究,并进行了描述性整合。方法学质量不统一,其不同的优势/劣势归因于研究设计。大多数研究观察了暴露于拉莫三嗪后其对儿童神经发育的并没有显著影响。左乙拉西坦的高质量研究相对较少,迄今为止未得到结论。托吡酯、加巴喷丁和奥卡西平的数据非常有限,无法得出确切的结论。令人担忧的是,尚无关于艾司利卡西平、拉考沙胺、吡仑帕奈或唑尼沙胺的研究。到目前为止,暴露于某些新型ASMs(如拉莫三嗪和左乙拉西坦)似乎并未影响神经发育的特定方面,但需要在不同的神经发育方面和剂量水平上进行进一步的研究。由于缺乏数据,无法确定新型ASMs的安全性,这些尚待进一步研究。

    Release date:2023-01-04 02:32 Export PDF Favorites Scan
  • Prevalence Rate of Nosocomial Infection from 2011 to 2013

    ObjectiveTo analyze the trend of hospital infection, so as to provide a scientific basis for hospital infection prevention and control. MethodsFrom 2011 to 2013, according to the criteria of diagnosis of nosocomial infections set up by the Ministry of Health, the prevalence rates of nosocomial infections in patients who were hospitalized on the survey day were investigated by the combination of bedside investigation and medical records checking. ResultsThe incidence rates of nosocomial infections from 2011 to 2013 were 2.99%, 2.31% and 1.95%, respectively, presenting a downward trend. The rate of hospital infection was the highest in comprehensive Intensive Care Unit, and the main infection site was the lower respiratory tract. Gram-negative bacteria were the main pathogens causing hospital infections, including Klebliella pnermoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii and Escherichia coli. The utilization rates of antibacterial agents in these three years were respectively 39.84%, 34.58% and 34.22%. ConclusionTargeted surveillance and management of key departments and sites should be strengthened. It is necessary to strengthen the surveillance and management of antibiotics, raise the submission rate of pathogens, and use antibiotics appropriately.

    Release date: Export PDF Favorites Scan
  • The effects of intervention with Tanakan on anterior ocular segment in diabetic retinopathy after retinal photocoagulation

    Purpose To investigate the effects of intervention with Tanakan on anterior ocular segment in diabetic retinopathy (DR) after retinal photocoagulation. Methods Prospective random controlled study was performed on 72 patients (72 eyes) with ultrasound biomicroscopy (UBM),by obtaining and quantitatively analyzing the changes of anterior ocular segment including anterior chamber, anterior chamber angle, ciliary body and choroids before and the 3rd day and the 7th day after retinal photocoagulation. Results Three days after photocoagulation, significant elev ated IOP and narrowed chamber angle were observed in control group and 4 eyes (1 1.11%) in Tanakan group (Plt;0.01). Choroidal detachment in 32 eyes (88.89%) in control group and in 2 eyes (5.56%) in Tanakan group and the severity of ciliochoroidal detachment in tanakan group was significantly lower than that in control group. Conclusion Tanakan is effective to prevent the complications of anterior segment, such as ciliochoroidal detachment, elevation of IOP, narrowing of chamber angle occurring early after retinal photocoagulation and reduce the severity of ciliochoroidal detachment. (Chin J Ocul Fundus Dis, 2001,17:187-189)

    Release date:2016-09-02 06:03 Export PDF Favorites Scan
  • 深部脑刺激治疗药物难治性癫痫的研究现状

    癫痫是一种短暂性脑神经异常放电引起人体机能出现异常的一种疾病,该疾病目前已然波及全球5 000万余人,人们通常使用药物控制发作,尽管引入了各种新型抗癫痫发作药物(Anti-seizure medications,ASMs),仍有约1/3的患者无法通过ASMs正规治疗得到有效控制,进而发展为药物难治性癫痫(Drug-resistant epilepsy,DRE),持续的癫痫发作会对患者的身体、心理、家庭以及社会造成严重的负担。随着神经外科对立体定向技术的逐步深入研究,研究发现深部脑刺激(Deep brain stimulation,DBS)是一种广泛应用于精神和神经疾病的有效治疗手段,目前,DBS在治疗帕金森病(Parkinson’s disease,PD)方面已取得良好成效,同时该技术的可调节性、可逆性及良好的安全性促使人们通过DBS对精神神经系统疾病进行更深入的研究。目前世界各地已有一定数量的患有不同精神障碍或神经障碍的患者接受DBS治疗,其运用于DRE也得到了良好疗效,本文就DBS的神经调控机制、相关靶点、副作用及研究现状作如下概述,以期对DRE的治疗提供治疗新思路。

    Release date:2023-03-13 02:15 Export PDF Favorites Scan
  • 道诺霉素及脂质体对玻璃体切除兔眼视网膜的毒性

    Release date: Export PDF Favorites Scan
  • 玻璃体腔注射雷珠单抗治疗病理性近视脉络膜新生血管的疗效观察

    Release date: Export PDF Favorites Scan
  • Evidence-Based Evaluation and Selection of Essential Medicine for Township Health Centre in China: 12. Antihypertensive Medicin

    Objective To evaluate and select essential antihypertensive medicine using evidence-based approaches based on the burden of disease for township health centers located in eastern, central and western regions of China. Methods By means of the approaches, criteria, and workflow set up in the second article of this series, we referred to the recommendations of evidence-based or authority guidelines from inside and outside China, collected relevant evidence from domestic clinical studies, and recommended essential medicine based on evidence-based evaluation. Data were analyzed by Review Manager (RevMan) 5.1 and GRADE profiler 3.6 to evaluate quality of evidence. Results (1) Five clinical guidelines on hypertension were included, two of which were evidence-based. (2) Totally there were nine classes and 70 antihypertensive medicines listed in the guidelines. (3) According to WHOEML (2011), NEML (2009), CNF (2010), other guidelines, and the quantity and quality of evidence, we offered a b recommendation for nifedipine, verapamil and enalapril and a weak recommendation for hydrochlorothiazide, indapamide, spironolactone, propranolol, metoprolol and amlodipine. We made a recommendation against furosemide and timolol due to the lack of evidence from guidelines. (4) Nine recommended medicines have been marketed with the dosage forms and specifications corresponding to guidelines in China. The prices of metoprolol, amlodipine and enalapril were higher than those of other six (daily cost: metoprolol 3.80 to 7.60 yuan, amlodipine 2.16 to 4.32 yuan, and enalapril 0.86 to 6.88 yuan). As a whole, the prices of recommended antihypertensive medicine were affordable. (5) Results of domestic studies indicated that three bly-recommended medicines (including nifedipine, verapamil and enalapril) were safe, effective, economical and applicable. Conclusion (1) We offer a b recommendation for nifedipine, verapamil and enalapril as antihypertensive medicine and a weak recommendation for hydrochlorothiazide, indapamide, spironolactone, propranolol, metoprolol and amlodipine. (2) There is lack of high-quality evidence from relevant domestic studies, especially on long-term safety and pharmacoeconomic evidence. (3) We propose that more studies should be carried out on the safety, efficacy and pharmacoeconomics of six medicines for which we make a weak recommendation to produce high-quality local evidence.

    Release date:2016-09-07 11:00 Export PDF Favorites Scan
  • Intravitreous injection with triamcinolone acetonide for cystoid macular edema due to central retinal vein occlusion

    ObjectiveTo investigate the efficacy and safety of intravitreous injection with triamcinolone acetonide (TA) for cystoid macular edema (CME) due to central retinal vein occlusion (CRVO).MethodsFourteen eyes of 14 patients with CME due to CRVO underwent intravitreous injection with 0.1 ml TA (40 mg/ml). Best-corrected visual acuity, intraocular pressure (IOP), slitlamp examinaion, fundus fluorescein angiography, and optical coherence tomography (OCT) were performed on the patients before and after the injection. The follow-up period was 10-22.4 months, with the mean of 15.9 months.ResultsThe average visual acuity was 0.1 before the treatment; while 1 month and 3 months after the injection, the visual acuity of all of the patients improved, including ≥0.2 in 71.43% and 63.6% of the patients, respectively, and ≥0.5 in 429% and 27.3%, respectively. After then, the visual acuity of some patients decreased, and in the final visit, 4 eyes (28.6%) had a visual acuity of ≥0.2, and 1 eye (7.1%) of ≥0.5. Compared with that before the treatment, the visual acuity of 10 (71.4%) eyes improved and 4 (28.6%) eyes declined. One month after the treatment, the macular edema disappeared in 10 eyes (71.4%) and alleviated in 4 (28.6%). In the final visit, macular edema disappeared in 4 eyes, alleviated in 9, and aggravated in 1. In the follow-up duration, high IOP[22.3-40.1 mm Hg (1 mm Hg=0.133 kPa)]. In the final visit, posterior subcapsular cataract was found in 7 eyes.ConclusionIntravitreous injection with TA may be effective in reducing CME and enhancing the visual acuity in a short term with high IOP in some eyes. In the long-term follow-up period, the rate of recurrence of CME and incidence of posterior subcapsular cataract is high. (Chin J Ocul Fundus Dis, 2005,21:213-216)

    Release date:2016-09-02 05:52 Export PDF Favorites Scan
  • Advances and challenges in pharmacotherapy for obesity in China

    Obesity is a chronic metabolic disease driven by multiple factors such as genetic susceptibility, environmental factors, and neuroendocrine system disorders. In recent years, the prevalence of obesity in China has been increasing year by year, and a series of obesity-induced diseases are a serious threat to public health. Glucagon-like peptide-1 receptor agonists, as a representative of the new weight loss drugs, have shown a therapeutic effect close to that of weight-loss metabolic surgery in clinical trials by targeting central appetite and metabolism and other synergistic effects, but they still face key problems such as significant differences in individual efficacy, limited evidence of the safety of long-term treatment, and regaining body weight after discontinuation of the drug. The mechanism of action and clinical evidence of several obesity drugs approved and listed in China are summarized, and the progress and challenges of obesity drug therapy in China in combination with recent advances in the development of multi-target agents internationally are discussed, with a view to providing a scientific basis for the clinical drug management of obesity and providing ideas for the research and development of obesity drugs in China as well as for the clinical transformation.

    Release date:2025-09-22 03:59 Export PDF Favorites Scan
  • Analysis of randomized controlled trials on information of comumonly-used digestive-related medicines

    Objective To appraise the current situation of randomized controlled trials (RCTs) on information of common-used digestive-related medicines afforded by medicine-salesmen. Methods RCTs on digestive-related medicines were assessed according to clinical epidemiologic standard. Results 60 medicines containing 252 therapeutic articles were searched and 75 RCTs were identified and assessed. Conclusion The qualities and quantities of RCTs of information on digestive-related medicines were of large difference, the RCTs afforded by the joint pharmaceutical enterprises are much better than those of foreign ones and domestic ones.

    Release date:2016-08-25 03:16 Export PDF Favorites Scan
96 pages Previous 1 2 3 ... 96 Next

Format

Content